Patenting perspective on Keap1 inhibitors (2019-2024)

被引：0
|
作者：
Luo, Yongfu [1 ]
Yang, Ziyu [1 ]
Zhang, Yuan [1 ]
Jiang, Shutong [1 ]
Zhu, Jingyu [1 ]
Li, Xiangyang [1 ,2 ]
You, Qidong [1 ,3 ,4 ,5 ]
Lu, Mengchen [1 ]
机构：
[1] Soochow Univ, Coll Pharmaceut Sci, Med Coll, Dept Med Chem, Suzhou 215123, Peoples R China
[2] Microcell Pharmaceut Suzhou Co Ltd, Dept Res & Dev, Suzhou, Peoples R China
[3] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, TongJiaXiang 24, Nanjing 210009, Peoples R China
[4] China Pharmaceut Univ, State Key Lab Nat Med, TongJiaXiang 24, Nanjing 210009, Peoples R China
[5] China Pharmaceut Univ, Nanjing 211198, Peoples R China
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2025年 / 35卷 / 04期
基金：
中国国家自然科学基金;
关键词：
Keap1; Nrf2; oxidative stress; electrophilic inhibitors; protein-protein interaction inhibitors; PROTEIN-PROTEIN INTERACTION; FUMARIC-ACID ESTERS; OXIDATIVE STRESS; DIMETHYL FUMARATE; MULTIPLE-SCLEROSIS; KELCH DOMAIN; NRF2; PATHWAY; ACTIVATION; BINDING; REDOX;
D O I：
10.1080/13543776.2025.2462844
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
IntroductionKelch-like ECH-associated protein 1 (Keap1), an E3 ligase negatively regulating the nuclear factor erythroid 2-related factor 2 (Nrf2), has emerged as an auspicious drug target for treating ailments associated with oxidative stress and inflammation. Discovery of Keap1 inhibitors have attracted significant interest. Areas coveredThis review covers patents on Keap1 inhibitors from 2019 to 2024, providing a comprehensive analysis of their structural characteristics, optimization strategies, pharmacological properties and clinical progress. Expert opinionExtensive efforts have been devoted to enhance potency and drug-like properties of Keap1 inhibitors. Strategies such as ROS-cleavable prodrug design, bivalent inhibition and PROTACs are emerging. As the range of drug types and applications expands, Keap1 inhibitors are becoming a sagacious option for disease treating.
引用
收藏
页码：325 / 356
页数：32
相关论文
共 50 条
  • [21] Betaine activates the Nrf2-Keap1-ARE pathway by increasing the methylation level of Keap1 DNA promoter
    Zhang, Mengmeng
    Wang, Tianchui
    Ou, Sixian
    Zou, Yucong
    Xin, Xuan
    INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, 2024, 59 (09): : 6231 - 6242
  • [22] Role of the Keap1/Nrf2 pathway in neurodegenerative diseases
    Yamazaki, Hiromi
    Tanji, Kunikazu
    Wakabayashi, Koichi
    Matsuura, Shin
    Itoh, Ken
    PATHOLOGY INTERNATIONAL, 2015, 65 (05) : 210 - 219
  • [23] Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer
    Ahtikoski, Anne M.
    Kangas, Juha
    Salonen, Riikka
    Puistola, Ulla
    Karihtala, Peeter
    ANTICANCER RESEARCH, 2019, 39 (02) : 585 - 590
  • [24] The Pleiotropic Role of the KEAP1/NRE2 Pathway in Cancer
    Wu, Warren L.
    Papagiannakopoulos, Thales
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 413 - 435
  • [25] Z-REX uncovers a bifurcation in function of Keap1 paralogs
    Van Hall-Beauvais, Alexandra
    Poganik, Jesse R.
    Huang, Kuan-Ting
    Parvez, Saba
    Zhao, Yi
    Lin, Hong-Yu
    Liu, Xuyu
    Long, Marcus John Curtis
    Aye, Yimon
    ELIFE, 2022, 11
  • [26] Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
    Isohookana, Joel
    Haapasaari, Kirsi-Maria
    Soini, Ylermi
    Karihtala, Peeter
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [27] Structural hybridization for inhibitors of the interaction between NRF2 and Keap1
    Lee, Dong Heun
    Seo, Seon Hee
    Gotina, Lizaveta
    Pae, Ae Nim
    Lim, Sang Min
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2022, 43 (09) : 1088 - 1092
  • [28] Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
    Mou, Yi
    Wen, Shuai
    Li, Yu-Xiu
    Gao, Xin-Xing
    Zhang, Xin
    Jiang, Zheng-Yu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 202
  • [29] Identification of novel indole derivatives acting as inhibitors of the Keap1-Nrf2 interaction
    Cosimelli, Barbara
    Greco, Giovanni
    Laneri, Sonia
    Novellino, Ettore
    Sacchi, Antonia
    Amendola, Giorgio
    Cosconati, Sandro
    Bortolozzi, Roberta
    Viola, Giampietro
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 1152 - 1157
  • [30] Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
    Pallesen, Jakob S.
    Narayanan, Dilip
    Tran, Kim T.
    Solbak, Sara M. O.
    Marseglia, Giuseppe
    Sorensen, Louis M. E.
    Hoj, Lars J.
    Munafo, Federico
    Carmona, Rosa M. C.
    Garcia, Anthony D.
    Desu, Haritha L.
    Brambilla, Roberta
    Johansen, Tommy N.
    Popowicz, Grzegorz M.
    Sattler, Michael
    Gajhede, Michael
    Bach, Anders
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (08) : 4623 - 4661
12345